Navigation Links
Pain Killers To Carry Warnings About Heart Attack And Stroke Risk

Pain killers which are commonly used for a number of painful complaints, have been shown to increase the risk of heart attack and stroke//. This has lead to an order by the Commission on Human Medicines whereby these drugs will have to carry a warning along with the information put on them by the manufacturers.

Doctors are being informed of the small but increased risk in long term treatment with high doses of these drugs. These are used very commonly for conditions of chronic pain in osteoarthritis and rheumatoid arthritis, and are known as Non Steroidal Anti Inflammatory Drugs (NSAID).

Studies have shown that high doses(around 2400 mg) of these drugs increase the risk of heart attack, and an investigation into NSAIDs was launched last month by the European Medicines Agency.

Diclofenac, etodolac, ibuprofen, indomethacin, ketoprofen, ketorolac, meloxicam, nabumetone, naproxen, and nimesulide are the NSAIDS which have been reviewed. Low dose (400mg) ibuprofen which is an OTC drug is considered safe and will not have to include the cautionary information.

The director for vigilance and risk management, Medicines and Healthcare products Regulatory Agency, Dr. June Raine, said that the benefits of the drugs are still considered to outweigh the risks, and that it was not required that patients stop their medications if they felt well. However it is advisable to keep the treatment as low dose and short term as possible.
MAL
'"/>




Page: 1

Related medicine news :

1. Pain Killers Keep the Virus Away
2. Heart Related Problems-The Largest Killers In Andhra Pradesh
3. Cereal Killers: Is the Loaded Breakfast Bowl Really Healthy?
4. Copper Alloys Surfaces Touted As Pathogen Killers
5. Preventive Mastectomy Does Not Carry Emotional Baggage For Most Women
6. Well-Planned Surgeries Also Carry Health Risks
7. Cigarette Packets to Carry Skull-and-bones Sign
8. Apollo Group Permitted to Carry out Surgeries in its Oman Centre
9. Babies at Hospital found to Carry Super bug MRSA
10. Allergic Individuals Should Carry Two Doses Of EpiPen Says Quebec Coroner
11. Skin Lightening Products Carry Risk of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: